TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

FDA Approves Brain Tumor Warning For Pfizer's Depo-Provera Amid Lawsuit

Benzinga Logo Benzinga By Vandana Singh
FDA Approves Brain Tumor Warning For Pfizer's Depo-Provera Amid Lawsuit

The FDA approved a label change for Pfizer's Depo-Provera contraceptive injection, adding a warning about meningioma brain tumor risks amid ongoing lawsuits from over 1,000 women alleging inadequate safety disclosures.

Insights
SNDK   positive

Up 480% in three months, doubled earnings expectations, 22% year-over-year revenue growth, and filled order book through 2026


PFE   negative

Facing over 1,000 lawsuits, forced to update drug label with brain tumor warning, potential reputational and financial damage from legal challenges and safety concerns